Oragenics Inc (NYSEAMERICAN:OGEN) stock continues to gain for the third consecutive session on Friday. At the time of writing, OGEN stock is up as much as 25% and trading at the high point of the day at $0.92 on very high volume.
After a deep correction of over 50% from February’s high, the stock has rebounded strongly this week. In fact, the stock is up about 43% from Wednesday’s low $0.64. Nevertheless, the stock is still up 80% so far this year.
Earlier in March, the company announced an agreement with Biodextris Inc. for the use of three intranasal mucosal adjuvants in the Company’s Terra CoV-2 vaccine against COVID-19.
Well, a sharp recovery after a deep correction is always healthy and more importantly, the stock has gained back above its 200-day moving average of $0.79. Now the next level to keep an eye on would be $0.97 – which is its 50-Day moving average.